Angelico R, Grimaldi C, Gazia C, Saffioti MC, Manzia TM, Castellano A, Spada M (2019) How Do Synchronous Lung Metastases Influence the Surgical Management of Children with Hepatoblastoma? An Update and Systematic Review of the Literature Cancers (Basel), 11(11)

Aronson DC, Weeda VB, Maibach R, Czauderna P, Dall’Igna P, de Ville de J, Goyet S, Branchereau G, Perilongo P, Brock J, Zsiros M, Semeraro C, Chardot B, Wildhaber B, Morland, Brugières L (2019) Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report. Eur J Cancer 106:126–132

Article  PubMed  Google Scholar 

Bell D, Ranganathan S, Tao J, Monga SP (2017) Novel advances in understanding of Molecular Pathogenesis of Hepatoblastoma: a Wnt/β-Catenin perspective. Gene Expr 17(2):141–154

Article  CAS  PubMed  Google Scholar 

Collart FR, Chubb CB, Mirkin BL, Huberman E (1992) Increased inosine-5’-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines. Cancer Res 52(20):5826–5828

CAS  PubMed  Google Scholar 

Czauderna P, Lopez-Terrada D, Hiyama E, Häberle B, Malogolowkin MH, Meyers RL (2014) Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 26(1):19–28

Article  CAS  PubMed  Google Scholar 

Davies JQ, de la Hall PM, Kaschula RO, Sinclair-Smith CC, Hartley P, Rode H, Millar AJ (2004) Hepatoblastoma–evolution of management and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases. J Pediatr Surg 39(9):1321–1327

Article  CAS  PubMed  Google Scholar 

de Fine Licht S, Schmidt LS, Rod NH, Schmiegelow K, Lähteenmäki PM, Kogner P, Träger C, Stokland T, Schüz J (2012) Hepatoblastoma in the nordic countries. Int J Cancer 131(4):E555–E561

Article  PubMed  Google Scholar 

Duan S, Huang W, Liu X, Liu X, Chen N, Xu Q, Hu Y, Song W, Zhou J (2018) IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways. J Exp Clin Cancer Res 37(1):304

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fellenberg J, Bernd L, Delling G, Witte D, Zahlten-Hinguranage A (2007) Prognostic significance of drug-regulated genes in high-grade osteosarcoma. Mod Pathol 20(10):1085–1094

Article  CAS  PubMed  Google Scholar 

Gao G, Xue Q, He J, Wu M, Jiang Y, Li Q, Zhang Y, Shi W (2023) Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mTOR signaling pathway. Int Immunopharmacol, 125(Pt A): p. 111125

Gartel AL, Tyner AL (2002) The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1(8):639–649

CAS  PubMed  Google Scholar 

Haeberle B, Rangaswami A, Krailo M, Czauderna P, Hiyama E, Maibach R, Lopez-Terrada D, Aronson DC, Alaggio R, Ansari M, Malogolowkin MH, Perilongo G, O’Neill AF, Trobaugh-Lotrario AD, Watanabe K, Schmid I, von Schweinitz D, Ranganathan S, Yoshimura K, Hishiki T, Tanaka Y, Piao J, Feng Y, Rinaldi E, Saraceno D, Derosa M, Meyers RL (2020) The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: analysis from the children’s hepatic tumors international collaboration (CHIC) database. Pediatr Blood Cancer 67(8):e28350

Article  PubMed  Google Scholar 

He Y, Zheng Z, Xu Y, Weng H, Gao Y, Qin K, Rong J, Chen C, Yun M, Zhang J, Ye S (2018) Over-expression of IMPDH2 is associated with tumor progression and poor prognosis in hepatocellular carcinoma. Am J Cancer Res 8(8):1604–1614

CAS  PubMed  PubMed Central  Google Scholar 

Heck JE, Meyers TJ, Lombardi C, Park AS, Cockburn M, Reynolds P, Ritz B (2013) Case-control study of birth characteristics and the risk of hepatoblastoma. Cancer Epidemiol 37(4):390–395

Article  PubMed  PubMed Central  Google Scholar 

Hu H, Zhang W, Wang Y, Zhang Y, Yi Y, Gao Y, Chen L, Huang D (2021) Prognostic analysis for children with hepatoblastoma with lung metastasis: a single-center analysis of 98 cases. Asia Pac J Clin Oncol 17(5):e191–e200

Article  PubMed  Google Scholar 

Jia X, Liu Y, Cheng Y, Wang Y, Kang H, Ma Z, Chen K (2022) Inosine monophosphate dehydrogenase type1 sustains tumor growth in hepatocellular carcinoma. J Clin Lab Anal 36(5):e24416

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kofuji S, Hirayama A, Eberhardt AO, Kawaguchi R, Sugiura Y, Sampetrean O, Ikeda Y, Warren M, Sakamoto N, Kitahara S, Yoshino H, Yamashita D, Sumita K, Wolfe K, Lange L, Ikeda S, Shimada H, Minami N, Malhotra A, Morioka S, Ban Y, Asano M, Flanary VL, Ramkissoon A, Chow LML, Kiyokawa J, Mashimo T, Lucey G, Mareninov S, Ozawa T, Onishi N, Okumura K, Terakawa J, Daikoku T, Wise-Draper T, Majd N, Kofuji K, Sasaki M, Mori M, Kanemura Y, Smith EP, Anastasiou D, Wakimoto H, Holland EC, Yong WH, Horbinski C, Nakano I, DeBerardinis RJ, Bachoo RM, Mischel PS, Yasui W, Suematsu M, Saya H, Soga T, Grummt I, Bierhoff H, Sasaki AT (2019) IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma. Nat Cell Biol 21(8):1003–1014

Article  CAS  PubMed  PubMed Central  Google Scholar 

Linabery AM, Ross JA (2008) Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer 112(2):416–432

Article  PubMed  Google Scholar 

Lipsky JJ (1996) Mycophenolate mofetil. Lancet 348(9038):1357–1359

Article  CAS  PubMed  Google Scholar 

Marin JJG, Briz O, Herraez E, Lozano E, Asensio M, Di Giacomo S, Romero MR, Osorio-Padilla LM, Santos-Llamas AI, Serrano MA, Armengol C, Efferth T, Macias RIR (2018) Molecular bases of the poor response of liver cancer to chemotherapy. Clin Res Hepatol Gastroenterol 42(3):182–192

Article  CAS  PubMed  Google Scholar 

Mauro M, Rego MA, Boisvert RA, Esashi F, Cavallo F, Jasin M, Howlett NG (2012) p21 promotes error-free replication-coupled DNA double-strand break repair Nucleic Acids Res, 40(17): pp. 8348-60

Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P (2017) Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the children’s hepatic tumors international collaboration. Lancet Oncol 18(1):122–131

Article  PubMed  Google Scholar 

Monga SP (2015) β-Catenin signaling and roles in Liver Homeostasis, Injury, and Tumorigenesis. Gastroenterology 148(7):1294–1310

Article  CAS  PubMed  Google Scholar 

Natsumeda Y, Ohno S, Kawasaki H, Konno Y, Weber G, Suzuki K (1990) Two distinct cDNAs for human IMP dehydrogenase. J Biol Chem 265(9):5292–5295

Article  CAS  PubMed  Google Scholar 

Ni C, Liu W, Zheng K, Guo S, Song B, Jing W, Li G, Li B, Ni C, Shi K, Jin G, Yu G (2023) PI3K/ c-Myc/AFF4 axis promotes pancreatic tumorigenesis through fueling nucleotide metabolism. Int J Biol Sci 19(6):1968–1982

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peñuelas S, Noé V, Ciudad CJ (2005) Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells. Febs j 272(3):696–710

Article  PubMed  Google Scholar 

Ransom JT (1995) Mechanism of action of mycophenolate mofetil. Ther Drug Monit 17(6):681–684

Article  CAS  PubMed  Google Scholar 

Russell JO, Monga SP (2018) Wnt/β-Catenin signaling in Liver Development, Homeostasis, and Pathobiology. Annu Rev Pathol 13:351–378

Article  CAS  PubMed  Google Scholar 

Shireman JM, Atashi F, Lee G, Ali ES, Saathoff MR, Park CH, Savchuk S, Baisiwala S, Miska J, Lesniak MS, James CD, Stupp R, Kumthekar P, Horbinski CM, Ben-Sahra I, Ahmed AU (2021) De novo Purine Biosynth is Major Driv Chemoresistance Glioblastoma Brain 144(4):1230–1246

Google Scholar 

Shu Q, Nair V (2008) Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery. Med Res Rev 28(2):219–232

Article  CAS  PubMed  Google Scholar 

Suthanthiran M, Strom TB (1997) Immunoregulatory drugs: mechanistic basis for use in organ transplantation. Pediatr Nephrol 11(5):651–657

Article  CAS  PubMed  Google Scholar 

Trobaugh-Lotrario AD, Katzenstein HM (2012) Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategies. Pediatr Blood Cancer 59(5):809–812

Article  PubMed  Google Scholar 

Trobaugh-Lotrario AD, Meyers RL, Tiao GM, Feusner JH (2016) Pediatric liver transplantation for hepatoblastoma. Transl Gastroenterol Hepatol 1:44